These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12201077)

  • 1. Introduction. Modulite: simplifying the changeover.
    Bousquet J
    Respir Med; 2002 Aug; 96 Suppl D():S1-2. PubMed ID: 12201077
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulite: a means of designing the aerosols generated by pressurized metered dose inhalers.
    Ganderton D; Lewis D; Davies R; Meakin B; Brambilla G; Church T
    Respir Med; 2002 Aug; 96 Suppl D():S3-8. PubMed ID: 12201079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite).
    Bousquet J; Cantini L
    Respir Med; 2002 Aug; 96 Suppl D():S17-27. PubMed ID: 12201078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulite technology: pharmacodynamic and pharmacokinetic implications.
    Woodcock A; Acerbi D; Poli G
    Respir Med; 2002 Aug; 96 Suppl D():S9-15. PubMed ID: 12201080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budesonide Modulite: improving the changeover to CFC-free treatments.
    Magnussen H
    Respir Med; 2003 Nov; 97 Suppl D():S1-3. PubMed ID: 14753245
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydrofluoroalkane-beclomethasone versus chlorofluorocarbon-beclomethasone delivery in neonatal models.
    Cole CH; Mitchell JP; Foley MP; Nagel MW
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F417-8. PubMed ID: 15321960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corticoid dose aerosol without FCKW. New technology assures optimal particle size].
    MMW Fortschr Med; 2004 Mar; 146(10):46. PubMed ID: 15347087
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhaled beclomethasone dipropionate symposium.
    Newman SP; Pitcairn GR
    Respir Med; 1999 May; 93(5):366-9. PubMed ID: 10464906
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of HFA-BDP Autohaler with budesonide Turbuhaler in asthma control of adult patients with mild to moderately severe disease.
    Worth H
    Respir Med; 2000 Sep; 94 Suppl D():S27-30. PubMed ID: 11003172
    [No Abstract]   [Full Text] [Related]  

  • 10. GR106642X: a new, non-ozone depleting propellant for inhalers.
    Taggart SC; Custovic A; Richards DH; Woodcock A
    BMJ; 1995 Jun; 310(6995):1639-40. PubMed ID: 7795451
    [No Abstract]   [Full Text] [Related]  

  • 11. Issues surrounding MDI formulation development with non-CFC propellants.
    Kontny MJ; Destefano G; Jager PD; McNamara DP; Turi JS; Van Campen L
    J Aerosol Med; 1991; 4(3):181-7. PubMed ID: 10147677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Now that CFC inhalers for asthma are being pulled off the market, what type of inhalers are replacing them?
    Mayo Clin Womens Healthsource; 2008 Nov; 12(11):8. PubMed ID: 18836401
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible replacements for CFC-propelled metered-dose inhalers.
    Dalby RN
    Med Device Technol; 1991 May; 2(4):21-5. PubMed ID: 10149436
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
    Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
    Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.
    Braunstein G; Sharma R
    Respir Med; 2000 Jun; 94 Suppl B():S1-2. PubMed ID: 10919678
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotine microaerosol inhaler.
    Andrus PG; Rhem R; Rosenfeld J; Dolovich MB
    Can Respir J; 1999; 6(6):509-12. PubMed ID: 10623787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroflourocarbon- and hydrofluoroalkalane-cromolyn sodium for asthma: the issue of equivalence trials.
    Avila PC
    J Allergy Clin Immunol; 1998 Sep; 102(3):529-30. PubMed ID: 9768600
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of inhalant medications with and without chlorofluorocarbon propellants in the United States, 1996-2000.
    Wysowski DK; Swann J
    J Allergy Clin Immunol; 2002 Jul; 110(1):51-3. PubMed ID: 12110819
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA approves new inhaler without CFCs.
    FDA Consum; 2001; 35(4):3. PubMed ID: 11692883
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bronchial asthma. Small bronchi are not spared].
    MMW Fortschr Med; 2002 May; 144(18):64. PubMed ID: 12422715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.